热门资讯> 正文

Lexeo Therapeutics推出股票和招股说明书

2025-10-17 04:37

Lexeo Therapeutics (NASDAQ:LXEO) on Thursday said it has started an underwritten public offering and concurrent private placement of its common stock and pre-funded warrants.
The biotech company plans to offer shares to the public and sell additional shares and warrants to Balyasny Asset Management in a private placement exempt from SEC registration.
The private placement’s completion is not contingent on the public offering, Lexeo said.
The size and timing of the offerings will depend on market conditions.

LXEO -2.62% after hours to $8.54.
Source: Press Release

More on Lexeo Therapeutics

Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback
Lexeo Therapeutics, Inc. (LXEO) Regulatory Update And Interim Phase 1/2 Data Update For LX2006 For The Treatment Of Friedreich Ataxia Cardiomyopathy
Lexeo climbs after regulatory update on Friedreich ataxia drug
Seeking Alpha’s Quant Rating on Lexeo Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。